Prevenar 20, Injektionssuspension in einer Fertigspritze (polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 6B conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 8 conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 9V conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 10A conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 11A conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 12F conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 15B conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 18C conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 19F conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 22F conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 23F conjugata cum proteino corynebacteriae diphtheriae CRM 197 + polysaccharida streptococci pneumoniae typus 33F conjugata cum proteino corynebacteriae diphtheriae CRM 197) est un médicament commercialisé en Suisse. Retrouvez ici composition, prix, équivalents.
| Substance | Dosage | Pour |
|---|---|---|
| polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 6B conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 8 conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 9V conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 10A conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 11A conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 12F conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 15B conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 18C conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 19F conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 22F conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 23F conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| polysaccharida streptococci pneumoniae typus 33F conjugata cum proteino corynebacteriae diphtheriae CRM 197 | — | — |
| Nom commercial | Dosage | Forme | Prix | P/G |
|---|---|---|---|---|
| Prevenar 13, Injektionssuspension in einer Fertigspritze | — | Injektionssuspension in einer Fertigspritze | 77,70 CHF | — |
| Vaxneuvance, Injektionssuspension | — | Injektionssuspension | 77,95 CHF | — |
Non. Le registre national classe Prevenar 20, Injektionssuspension in einer Fertigspritze parmi les médicaments soumis à prescription médicale : une ordonnance est exigée pour sa délivrance.
Le prix public de Prevenar 20, Injektionssuspension in einer Fertigspritze est de 80,80 CHF. Aucune information de remboursement n'est publiée pour cette présentation.
Oui : 2 médicaments commercialisés en Suisse contiennent la même substance active.
La classe pharmacothérapeutique de Prevenar 20, Injektionssuspension in einer Fertigspritze est identifiée par son code ATC. Son code ATC est J07AL02.